Cannabigerol: The Cannabinoid With Potential Medical Benefits
According to research, by 2028, the market for minor cannabinoids is expected to reach $26 billion in the United States alone. Cannabigerol, also known as CBG, is a lesser-known cannabinoid. As far as we know, THC and CBD are the only cannabinoids studied in any actual capacity. However, cannabigerol is no less important. Some data indicate that …